title: Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays.
abstract: Sensitive and selective methods for the detection of human growth hormone (hGH) over a wide range of concentrations (high levels of 50-100 ng ml(-) (1) and minimum levels of 0.03 ng ml(-) (1)) in circulating blood are essential as variable levels may indicate altered physiology. For example, growth disorders occurring in childhood can be diagnosed by measuring levels of hGH in blood. Also, the misuse of recombinant hGH in sports not only poses an ethical issue it also presents serious health threats to the abuser. One popular strategy for measuring hGH misuse, relies on the detection of the ratio of 22 kDa hGH to total hGH, as non-22 kDa endogenous levels drop after exogenous recombinant hGH (rhGH) administration. Surface plasmon resonance imaging (SPRi) is an analytical tool that allows direct (label-free) monitoring and visualization of biomolecular interactions by recording changes of the refractive index adjacent to the sensor surface in real time. In contrast, the most frequently used colorimetric method, enzyme-linked immunosorbent assay (ELISA) uses enzyme labeled detection antibodies to indirectly measure analyte concentration after the addition of a substrate that induces a color change. To increase detection sensitivity, amplified SPRi uses a sandwich assay format and near infrared quantum dots (QDs) to increase signal strength. After direct SPRi detection of recombinant rhGH in spiked human serum, the SPRi signal is amplified by the sequential injection of detection antibody coated with near-infrared QDs (Nano-SPRi). In this study, the diagnostic potential of direct and amplified SPRi was assessed for measuring rhGH spiked in human serum and compared directly with the capabilities of a commercially available ELISA kit.
authors.affiliation: Department of Nanoscience, University of North Carolina at Greensboro.
authors.forename: Stephen
authors.initials: S
authors.lastname: Vance
authors.affiliation: Department of Nanoscience, University of North Carolina at Greensboro.
authors.forename: Effat
authors.initials: E
authors.lastname: Zeidan
authors.affiliation: Center for Biotechnology, Genomics, and Health Research, University of North Carolina at Greensboro.
authors.forename: Vincent C
authors.initials: VC
authors.lastname: Henrich
authors.affiliation: HORIBA Scientific; m_sandro@uncg.edu.
authors.forename: Marinella G
authors.initials: MG
authors.lastname: Sandros
mesh_terms: D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D019382:Human Growth Hormone / Q000097:blood*; D006801:Humans; D036103:Nanotechnology / Q000379:methods; D045663:Quantum Dots; D011994:Recombinant Proteins / Q000097:blood; D020349:Surface Plasmon Resonance / Q000379:methods*
chemical_list: D011994:Recombinant Proteins; D019382:Human Growth Hormone